Medicenna Therapeutics Corp (OTC:MDNAF) Stock Surges 22%: What’s The Buzz?

April 25, 2024

The clinical-stage immunotherapy company Medicenna Therapeutics Corp. (OTC:MDNAF) is involved in the development of Superkines, and on April 24, it was in focus following a key announcement. The company announced yesterday that it would make the presentations for a pair of abstracts at the Annual Meeting of the American Society of Clinical Oncology that would be held from May 31 to June 4 in Chicago. The abstracts would also include…

Read More >>